Related Experiment Video
Updated: Jan 5, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen1, Yucen Song2, Wei Du3
1Genetic and Prenatal Diagnosis Center, Department of Gynecology and Obstetrics, First Affiliated Hospital, Zhengzhou University, 1 Jianshe Road East, Zhengzhou, 450052, Henan, China. chenyibing@zzu.edu.cn.
Tumor-associated macrophages (TAMs) drive solid tumor progression and resistance to cancer therapies. Targeting TAMs offers a promising therapeutic strategy for improving patient survival in solid tumors.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment (TME) of many solid tumors.
- TAM infiltration correlates with poorer patient survival across various solid tumor types.
Purpose of the Study:
- To review the origins and polarization of TAMs within the TME.
- To elucidate the multifaceted roles of TAMs in promoting tumor growth, therapeutic resistance, angiogenesis, invasion, metastasis, and immunosuppression.
- To discuss TAMs as viable therapeutic targets in clinical settings.
Main Methods:
- Literature review focusing on the biology and clinical relevance of TAMs.
- Analysis of TAM functions including promotion of tumor growth, treatment resistance, angiogenesis, and metastasis.
- Exploration of therapeutic strategies targeting TAMs.
Main Results:
- TAMs originate from monocytes and adopt polarization states influenced by the TME.
- TAMs actively promote tumor progression through various mechanisms, including enhancing chemo- and radioresistance.
- TAMs play a critical role in tumor angiogenesis, migration, invasion, metastasis, and immune suppression.
Conclusions:
- TAMs are crucial mediators of solid tumor progression and therapeutic resistance.
- Targeting TAMs, through strategies like macrophage depletion or activation modulation, presents a promising avenue for cancer therapy.
- Further research into TAM-targeted therapies could significantly improve outcomes for solid tumor patients.
Related Concept Videos
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation

